Analyze Diet
The Veterinary clinics of North America. Equine practice2018; 34(1); 155-168; doi: 10.1016/j.cveq.2017.11.013

Practical Fluid Therapy and Treatment Modalities for Field Conditions for Horses and Foals with Gastrointestinal Problems.

Abstract: With advances in technology and owner education, field management in equine veterinary medicine continues to evolve. Equine gastrointestinal disease is one of the most common types of emergencies evaluated by equine practitioners, and many of these patients can be effectively managed in the field. Although the equine veterinarian must make numerous decisions, fluid therapy, pain management, and antimicrobial use are 3 of the major choices that must be addressed when initiating field treatment of equine gastrointestinal disease. This article addresses the practical use of these 3 treatment categories that are essential to field practice.
Publication Date: 2018-03-15 PubMed ID: 29534809PubMed Central: PMC7126773DOI: 10.1016/j.cveq.2017.11.013Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses practical treatment methods for horses and foals with gastrointestinal problems that can be applied in the field, including fluid therapy, pain management, and antimicrobial use.

Understanding Equine Gastrointestinal Diseases

  • The research notes that gastrointestinal disease in horses is a common emergency that veterinarians encounter frequently. Understanding this medical condition and the suitable treatment modalities is crucial for effective veterinary practice.
  • Due to advancements in technology and improved knowledge among horse owners, the approach and management of gastrointestinal diseases in horses and foals have evolved significantly. The application of these advancements and skills in the field is the primary focus of the research.

Significance of Fluid Therapy, Pain Management, and Antimicrobial Use

  • One of the key treatments that the research emphasizes is fluid therapy. Horses suffering from gastrointestinal problems often face dehydration; hence fluid therapy becomes vital to their recovery.
  • Managing pain is another critical concern addressed in the research. Effective pain reduction methods can significantly improve the quality of life for the horse or foal and potentially alleviate some of the gastrointestinal symptoms.
  • Antimicrobial use is also an essential treatment for equine gastrointestinal disease. Antimicrobials can control and kill harmful bacteria that may be exacerbating the condition.

Field Treatment of Equine Gastrointestinal Disease

  • The study analyses practical applications of the above treatments effectively in the field. The field, in this context, refers to out-of- clinic situations, often in the animal’s natural environment. Hence, the research provides solutions that can be applied on the spot, reducing the need for hospitalisation.
  • Such approaches can be greatly beneficial, considering economic factors and the practicality of transporting a large animal such as a horse to a medical facility. The research stresses that opting for field treatment can provide effective results given the treatments are applied correctly and promptly by a skilled veterinarian.

Importance of Decision-Making in Treatment

  • The research reminds veterinarians of the crucial importance of making informed and fast decisions when treating equine gastrointestinal disease in the field.
  • The various decisions include choosing the appropriate treatments and their proper application. The ability to make these decisions efficiently can significantly affect the outcome of the treatment and the health of the horse or foal.

Cite This Article

APA
Fielding CL. (2018). Practical Fluid Therapy and Treatment Modalities for Field Conditions for Horses and Foals with Gastrointestinal Problems. Vet Clin North Am Equine Pract, 34(1), 155-168. https://doi.org/10.1016/j.cveq.2017.11.013

Publication

ISSN: 1558-4224
NlmUniqueID: 8511904
Country: United States
Language: English
Volume: 34
Issue: 1
Pages: 155-168
PII: S0749-0739(17)30926-4

Researcher Affiliations

Fielding, C Langdon
  • Loomis Basin Equine Medical Center, 2973 Penryn Road, Penryn, CA 95663, USA. Electronic address: langdonfielding@yahoo.com.

MeSH Terms

  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Infective Agents / administration & dosage
  • Fluid Therapy / methods
  • Fluid Therapy / veterinary
  • Gastrointestinal Diseases / therapy
  • Gastrointestinal Diseases / veterinary
  • Horse Diseases / therapy
  • Horses

References

This article includes 30 references
  1. Vega RM, Avner JR. A prospective study of the usefulness of clinical and laboratory parameters for predicting percentage of dehydration in children.. Pediatr Emerg Care 1997 Jun;13(3):179-82.
  2. Pritchard JC, Burn CC, Barr AR, Whay HR. Validity of indicators of dehydration in working horses: a longitudinal study of changes in skin tent duration, mucous membrane dryness and drinking behaviour.. Equine Vet J 2008 Sep;40(6):558-64.
    pubmed: 18356129doi: 10.2746/042516408x297462google scholar: lookup
  3. Lopes MA, White NA 2nd, Donaldson L, Crisman MV, Ward DL. Effects of enteral and intravenous fluid therapy, magnesium sulfate, and sodium sulfate on colonic contents and feces in horses.. Am J Vet Res 2004 May;65(5):695-704.
    pubmed: 15141893doi: 10.2460/ajvr.2004.65.695google scholar: lookup
  4. Lopes MA, Walker BL, White NA 2nd, Ward DL. Treatments to promote colonic hydration: enteral fluid therapy versus intravenous fluid therapy and magnesium sulphate.. Equine Vet J 2002 Jul;34(5):505-9.
    pubmed: 12358055doi: 10.2746/042516402776117782google scholar: lookup
  5. Hallowell GD. Retrospective study assessing efficacy of treatment of large colonic impactions.. Equine Vet J 2008 Jun;40(4):411-3.
    pubmed: 18321804doi: 10.2746/042516408x288282google scholar: lookup
  6. Lester GD, Merritt AM, Kuck HV, Burrow JA. Systemic, renal, and colonic effects of intravenous and enteral rehydration in horses.. J Vet Intern Med 2013 May-Jun;27(3):554-66.
    pubmed: 23551797doi: 10.1111/jvim.12073google scholar: lookup
  7. Fielding L. Crystalloid and colloid therapy.. Vet Clin North Am Equine Pract 2014 Aug;30(2):415-25, viii-ix.
    pubmed: 25016499doi: 10.1016/j.cveq.2014.04.008google scholar: lookup
  8. Higgins J. Preparation supplies and catheterization. In: Fielding C.L., Magdesian K.G., editors. Equine fluid therapy. 1st edition. Wiley-Blackwell; Hoboken (NJ): 2015. pp. 129–141.
  9. Nolen-Walston RD. Flow rates of large animal fluid delivery systems used for high-volume crystalloid resuscitation.. J Vet Emerg Crit Care (San Antonio) 2012 Dec;22(6):661-5.
  10. Lopes M.A. Enteral fluid therapy. In: Fielding C.L., Magdesian K.G., editors. Equine fluid therapy. 1st edition. Wiley-Blackwell; Hoboken (NJ): 2015. pp. 261–278.
  11. Marshall JF, Blikslager AT. The effect of nonsteroidal anti-inflammatory drugs on the equine intestine.. Equine Vet J Suppl 2011 Aug;(39):140-4.
  12. McConnico RS, Morgan TW, Williams CC, Hubert JD, Moore RM. Pathophysiologic effects of phenylbutazone on the right dorsal colon in horses.. Am J Vet Res 2008 Nov;69(11):1496-505.
    pubmed: 18980433doi: 10.2460/ajvr.69.11.1496google scholar: lookup
  13. Holland B, Fogle C, Blikslager AT, Curling A, Barlow BM, Schirmer J, Davis JL. Pharmacokinetics and pharmacodynamics of three formulations of firocoxib in healthy horses.. J Vet Pharmacol Ther 2015 Jun;38(3):249-56.
    pubmed: 25378135doi: 10.1111/jvp.12177google scholar: lookup
  14. Cook VL, Meyer CT, Campbell NB, Blikslager AT. Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum.. Am J Vet Res 2009 Aug;70(8):992-1000.
    pubmed: 19645580doi: 10.2460/ajvr.70.8.992google scholar: lookup
  15. Traub-Dargatz JL, Bertone JJ, Gould DH, Wrigley RH, Weiser MG, Forney SD. Chronic flunixin meglumine therapy in foals.. Am J Vet Res 1988 Jan;49(1):7-12.
    pubmed: 3354970
  16. Roger T, Ruckebusch Y. Colonic alpha 2-adrenoceptor-mediated responses in the pony.. J Vet Pharmacol Ther 1987 Dec;10(4):310-8.
  17. Sutton DG, Preston T, Christley RM, Cohen ND, Love S, Roussel AJ. The effects of xylazine, detomidine, acepromazine and butorphanol on equine solid phase gastric emptying rate.. Equine Vet J 2002 Jul;34(5):486-92.
    pubmed: 12358052doi: 10.2746/042516402776117818google scholar: lookup
  18. Zullian C, Menozzi A, Pozzoli C, Poli E, Bertini S. Effects of α2-adrenergic drugs on small intestinal motility in the horse: an in vitro study.. Vet J 2011 Mar;187(3):342-6.
    pubmed: 20093057doi: 10.1016/j.tvjl.2009.12.015google scholar: lookup
  19. Mama KR, Grimsrud K, Snell T, Stanley S. Plasma concentrations, behavioural and physiological effects following intravenous and intramuscular detomidine in horses.. Equine Vet J 2009 Nov;41(8):772-7.
    pubmed: 20095225doi: 10.2746/042516409x421624google scholar: lookup
  20. Sanchez LC, Robertson SA, Maxwell LK, Zientek K, Cole C. Effect of fentanyl on visceral and somatic nociception in conscious horses.. J Vet Intern Med 2007 Sep-Oct;21(5):1067-75.
  21. Muir WW, Robertson JT. Visceral analgesia: effects of xylazine, butorphanol, meperidine, and pentazocine in horses.. Am J Vet Res 1985 Oct;46(10):2081-4.
    pubmed: 4062010
  22. Sellon DC, Roberts MC, Blikslager AT, Ulibarri C, Papich MG. Effects of continuous rate intravenous infusion of butorphanol on physiologic and outcome variables in horses after celiotomy.. J Vet Intern Med 2004 Jul-Aug;18(4):555-63.
  23. McGowan KT, Elfenbein JR, Robertson SA, Sanchez LC. Effect of butorphanol on thermal nociceptive threshold in healthy pony foals.. Equine Vet J 2013 Jul;45(4):503-6.
  24. Peiró JR, Barnabé PA, Cadioli FA, Cunha FQ, Lima VM, Mendonça VH, Santana AE, Malheiros EB, Perri SH, Valadão CA. Effects of lidocaine infusion during experimental endotoxemia in horses.. J Vet Intern Med 2010 Jul-Aug;24(4):940-8.
  25. Robertson SA, Sanchez LC, Merritt AM, Doherty TJ. Effect of systemic lidocaine on visceral and somatic nociception in conscious horses.. Equine Vet J 2005 Mar;37(2):122-7.
    pubmed: 15779623doi: 10.2746/0425164054223723google scholar: lookup
  26. Cook VL, Jones Shults J, McDowell MR, Campbell NB, Davis JL, Marshall JF, Blikslager AT. Anti-inflammatory effects of intravenously administered lidocaine hydrochloride on ischemia-injured jejunum in horses.. Am J Vet Res 2009 Oct;70(10):1259-68.
    pubmed: 19795941doi: 10.2460/ajvr.70.10.1259google scholar: lookup
  27. Uzal FA, Diab SS. Gastritis, Enteritis, and Colitis in Horses.. Vet Clin North Am Equine Pract 2015 Aug;31(2):337-58.
    pmc: PMC7127504pubmed: 26048413doi: 10.1016/j.cveq.2015.04.006google scholar: lookup
  28. Båverud V, Gustafsson A, Franklin A, Aspán A, Gunnarsson A. Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility.. Equine Vet J 2003 Jul;35(5):465-71.
    pubmed: 12875324doi: 10.2746/042516403775600505google scholar: lookup
  29. Dunkel B, Johns IC. Antimicrobial use in critically ill horses.. J Vet Emerg Crit Care (San Antonio) 2015 Jan-Feb;25(1):89-100.
    pubmed: 25582245doi: 10.1111/vec.12275google scholar: lookup
  30. Johns I, Tennent-Brown B, Schaer BD, Southwood L, Boston R, Wilkins P. Blood culture status in mature horses with diarrhoea: a possible association with survival.. Equine Vet J 2009 Feb;41(2):160-4.
    pubmed: 19418745doi: 10.2746/042516409x360208google scholar: lookup

Citations

This article has been cited 2 times.
  1. Crabtree NE, Epstein KL. Current Concepts in Fluid Therapy in Horses.. Front Vet Sci 2021;8:648774.
    doi: 10.3389/fvets.2021.648774pubmed: 33855057google scholar: lookup
  2. Thiemann AK, Sullivan RJE. Gastrointestinal Disorders of Donkeys and Mules.. Vet Clin North Am Equine Pract 2019 Dec;35(3):419-432.
    doi: 10.1016/j.cveq.2019.08.001pubmed: 31587977google scholar: lookup